Recursive Superintelligence raises $650M to build self-improving AI models

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched ...

Notable Researchers Join $4 Billion Effort to Build Self-Improving A.I.

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

How RecursiveMAS speeds up multi-agent inference by 2.4x and reduces token usage by 75%

UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% ...
Reuters

Formula 1

Russell confident momentum will swing back his way from Antonelli George Russell lost his tag of Formula One title favourite to Mercedes teammate Kimi Antonelli on Sunday but remained confident the ...

How the NFL uses AI to help solve its schedule-making puzzle

Airbnb prices, weather, local sporting events and even the economy impact an NFL fan’s likelihood to watch a game.
Yahoo Finance

Recursion Pharmaceuticals, Inc. (RXRX)

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...